Cytokinetics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 17.72 M | $1.13 B | -7.15% | 14.77% |
| BLACKROCK, INC. | 02/12/2026 | 16.40 M | $1.04 B | 5.60% | 13.66% |
| FMR LLC | 02/17/2026 | 12.81 M | $813.80 M | -2.17% | 10.67% |
| VANGUARD GROUP INC | 01/29/2026 | 12.05 M | $765.54 M | 1.61% | 10.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 7.94 M | $504.32 M | 7.13% | 6.62% |
| STATE STREET CORP | 02/13/2026 | 5.83 M | $370.14 M | 3.70% | 4.86% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 3.34 M | $212.03 M | -22.40% | 2.78% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.06 M | $194.21 M | 0.52% | 2.55% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 2.94 M | $186.88 M | -3.94% | 2.45% |
| RTW INVESTMENTS, LP | 02/17/2026 | 2.72 M | $172.90 M | 0.00% | 2.27% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 2.42 M | $153.93 M | -12.95% | 2.02% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 2.37 M | $150.70 M | 45.08% | 1.98% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 1.93 M | $122.64 M | -18.45% | 1.61% |
| WOODLINE PARTNERS LP | 02/17/2026 | 1.65 M | $104.74 M | 0.04% | 1.37% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 1.50 M | $95.31 M | 57.89% | 1.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.43 M | $90.74 M | 19.88% | 1.19% |
| JPMORGAN CHASE & CO | 02/11/2026 | 1.41 M | $89.77 M | -8.43% | 1.18% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/17/2026 | 1.40 M | $88.96 M | 0.00% | 1.17% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.38 M | $87.90 M | 0.70% | 1.15% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.38 M | $87.74 M | -1.85% | 1.15% |
| MORGAN STANLEY | 02/13/2026 | 1.27 M | $80.40 M | -16.82% | 1.05% |
| CAPITAL INTERNATIONAL INVESTORS | 02/11/2026 | 1.18 M | $74.90 M | 0.00% | 0.98% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.16 M | $73.89 M | -16.10% | 0.97% |
| UBS GROUP AG | 01/29/2026 | 1.13 M | $71.89 M | -37.25% | 0.94% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 992.77 K | $63.08 M | -17.05% | 0.83% |
| 04/01/2026 | 980.39 K | $62.29 M | 100.00% | 0.82% | |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 976.89 K | $62.07 M | -16.82% | 0.81% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 934.64 K | $59.39 M | 4.96% | 0.78% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 854.31 K | $54.28 M | -1.72% | 0.71% |
| JANE STREET GROUP, LLC | 02/12/2026 | 840.50 K | $53.41 M | 39.78% | 0.70% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 827.86 K | $52.60 M | 5.46% | 0.69% |
| FISHER ASSET MANAGEMENT, LLC | 02/09/2026 | 822.89 K | $52.29 M | 8.05% | 0.69% |
| NORGES BANK | 02/10/2026 | 807.07 K | $51.28 M | 100.00% | 0.67% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 800.00 K | $50.83 M | 128.57% | 0.67% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 757.56 K | $48.02 M | -33.87% | 0.63% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 753.62 K | $47.88 M | -25.96% | 0.63% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 02/11/2026 | 747.98 K | $47.53 M | -37.28% | 0.62% |
| BROWN ADVISORY INC | 02/13/2026 | 731.15 K | $46.46 M | -19.85% | 0.61% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 700.60 K | $44.52 M | 60.61% | 0.58% |
| MELQART ASSET MANAGEMENT (UK) LTD | 02/17/2026 | 622.90 K | $39.58 M | -20.53% | 0.52% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 579.86 K | $36.84 M | 134.32% | 0.48% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 545.81 K | $34.68 M | -3.32% | 0.45% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 544.01 K | $34.57 M | -19.02% | 0.45% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 540.17 K | $34.32 M | 4.09% | 0.45% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 537.28 K | $34.14 M | 5,844.64% | 0.45% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/17/2026 | 500.00 K | $31.77 M | -33.33% | 0.42% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 486.30 K | $30.90 M | 64.79% | 0.41% |
| FEDERATED HERMES, INC. | 02/12/2026 | 483.67 K | $30.73 M | 1,775.12% | 0.40% |
| ABRDN PLC | 01/16/2026 | 483.06 K | $30.69 M | -47.94% | 0.40% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 479.61 K | $30.47 M | 181.95% | 0.40% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cytokinetics Inc institutional Ownership - FAQ's
During the previous two years, 599 institutional investors and hedge funds held shares of Cytokinetics Inc. The most heavily invested institutionals were:
UBS Group AG: 2.08 M
PRINCIPAL FINANCIAL GROUP INC: 1.09 M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC: 1.09 M
Bank of New York Mellon Corp: 1.01 M
BNP PARIBAS ARBITRAGE, SNC: 854,374
Melqart Asset Management (UK) Ltd: 843,949
116.22% of Cytokinetics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 182.04 M shares in the last 24 months. This purchase volume represents approximately $11.36 B in transactions.